Updated cost-of-care estimates for commercially insured patients with multiple sclerosis: retrospective observational analysis of medical and pharmacy claims data

BACKGROUND: For patients with multiple sclerosis (MS), previous research identified key disease sequelae as important cost drivers and suggested that among users of disease-modifying drugs (DMDs) in 2004, DMDs represented 73% of the total cost of care. More recent studies were limited to incident di...

Descripción completa

Detalles Bibliográficos
Autores principales: Carroll, Cathryn A, Fairman, Kathleen A, Lage, Maureen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118272/
https://www.ncbi.nlm.nih.gov/pubmed/24986083
http://dx.doi.org/10.1186/1472-6963-14-286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118272/
https://www.ncbi.nlm.nih.gov/pubmed/24986083
http://dx.doi.org/10.1186/1472-6963-14-286

Ejemplares similares